• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concurrent vitiligo and atopic dermatitis successfully treated with upadacitinib: a case report.

作者信息

Pan Ting, Mu Yuzhu, Shi Xin, Chen Lingling

机构信息

Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.

Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

J Dermatolog Treat. 2023 Dec;34(1):2200873. doi: 10.1080/09546634.2023.2200873.

DOI:10.1080/09546634.2023.2200873
PMID:37026410
Abstract
摘要

相似文献

1
Concurrent vitiligo and atopic dermatitis successfully treated with upadacitinib: a case report.乌帕替尼成功治疗白癜风与特应性皮炎并存病例报告
J Dermatolog Treat. 2023 Dec;34(1):2200873. doi: 10.1080/09546634.2023.2200873.
2
Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib.乌帕替尼成功治疗同时患有慢性斑秃和重度特应性皮炎的患者
Int J Dermatol. 2022 Nov;61(11):e416-e417. doi: 10.1111/ijd.16316. Epub 2022 Jun 20.
3
Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report.乌帕替尼改善了一名特应性皮炎患者的斑秃：病例报告。
Dermatol Ther. 2022 Apr;35(4):e15346. doi: 10.1111/dth.15346. Epub 2022 Feb 10.
4
Repigmentation of vitiligo with topical tacrolimus.
Dermatology. 2002;205(3):301-3. doi: 10.1159/000065845.
5
Rapid improvement in pruritus in atopic dermatitis patients treated with upadacitinib: a real-life experience.使用乌帕替尼治疗的特应性皮炎患者瘙痒症状迅速改善：一项真实病例经验
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1497-1498. doi: 10.1111/jdv.18137. Epub 2022 Apr 18.
6
Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata.乌帕替尼对2例同时患有重度特应性皮炎和斑秃患者的双重疗效
Dermatitis. 2021 Oct 1;32(1S):e85-e86. doi: 10.1097/DER.0000000000000780.
7
Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib.奥达特罗单抗治疗特应性皮炎和溃疡性结肠炎疗效显著。
Medicina (Kaunas). 2023 Mar 10;59(3):542. doi: 10.3390/medicina59030542.
8
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.每日一次乌帕替尼对比安慰剂治疗中重度特应性皮炎青少年和成人患者（Measure Up1 和 Measure Up2）：两项复制性、双盲、随机对照 3 期临床试验结果。
Lancet. 2021 Jun 5;397(10290):2151-2168. doi: 10.1016/S0140-6736(21)00588-2. Epub 2021 May 21.
9
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.度普利尤单抗联合局部皮质类固醇治疗青少年和成人中重度特应性皮炎（AD Up）的安全性和有效性：一项随机、双盲、安慰剂对照、3 期临床试验的结果。
Lancet. 2021 Jun 5;397(10290):2169-2181. doi: 10.1016/S0140-6736(21)00589-4. Epub 2021 May 21.
10
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib.在使用乌帕替尼治疗期间，特应性皮炎向银屑病的表型转换。
Clin Exp Dermatol. 2022 May;47(5):986-987. doi: 10.1111/ced.15104. Epub 2022 Feb 2.

引用本文的文献

1
Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis.JAK抑制剂治疗白癜风的疗效与安全性：一项系统评价和Meta分析
Dermatol Ther (Heidelb). 2025 May 7. doi: 10.1007/s13555-025-01397-z.
2
Upadacitinib Monotherapy in Vitiligo Associated with Atopic Dermatitis: Killing Two Birds with One Stone.乌帕替尼单药治疗与特应性皮炎相关的白癜风：一石二鸟。
Case Rep Dermatol. 2025 Feb 28;17(1):91-95. doi: 10.1159/000544703. eCollection 2025 Jan-Dec.
3
Emerging Therapeutic Innovations for Vitiligo Treatment.
白癜风治疗的新兴治疗创新
Curr Issues Mol Biol. 2025 Mar 14;47(3):191. doi: 10.3390/cimb47030191.
4
Concurrent Refractory Atopic Dermatitis and Generalized Vitiligo Successfully Treated with Abrocitinib: A Case Report.阿巴西替尼成功治疗同时患有难治性特应性皮炎和泛发性白癜风：一例报告
J Asthma Allergy. 2024 Dec 3;17:1259-1263. doi: 10.2147/JAA.S492614. eCollection 2024.
5
Up-and-Coming Drugs for the Treatment of Vitiligo.治疗白癜风的新兴药物
Ann Dermatol. 2024 Aug;36(4):197-208. doi: 10.5021/ad.24.038.
6
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.合并症和特殊人群的中重度特应性皮炎患者的生物制剂和小分子治疗：意大利视角
Dermatol Reports. 2023 Sep 13;16(2):9839. doi: 10.4081/dr.2023.9839. eCollection 2024 Jun 14.
7
Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective.乌帕替尼及其在白癜风治疗中的作用：一种新的潜在治疗前景。
JAAD Case Rep. 2024 Feb 21;46:57-58. doi: 10.1016/j.jdcr.2024.01.033. eCollection 2024 Apr.
8
Vitiligo: Pathogenesis and New and Emerging Treatments.白癜风：发病机制与新型及新兴治疗方法。
Int J Mol Sci. 2023 Dec 9;24(24):17306. doi: 10.3390/ijms242417306.
9
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics.白癜风潜在治疗方法的最新进展：Janus激酶抑制剂和生物制剂。
J Clin Med. 2023 Dec 4;12(23):7486. doi: 10.3390/jcm12237486.